1. Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests;Evans;Mut. Res.,1975
2. EPA Health Effects Test Guidelines, OOPTS 870.5375, In Vitro Mammalian Cytogenetics, 1998.
3. ICH Topic S2A, Genotoxicity: guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals, in: Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Harmonized Tripartite Guideline CPMP/ICH/141/95, approved September 1995 (see http://www.ifpma.org/ich1.html), 1996.
4. OECD, OECD Guideline for Testing of Chemicals, Guideline 473, Genetic Toxicology: In Vitro Mammalian Chromosome Aberration Test, Organisation for Economic Cooperation and Development, Paris, 1997.
5. Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis;Juan;Cytometry,1998